Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 819

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT07487818
A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking …
Non-invasive vagus nerve stimulat… SEP Phase 2/3 RECRUITING En attente / non publié Mayo Clinic United States · Mayo Clinic in Rochester, Rochester, … 2026-06-04 → 2028-07 Ouvrir
NCT06822140
EVAMOS — Effect of Vagus Nerve Stimulation Via the Outer Ear on Motor a…
transcutaneous auricular vagus ne… SEP Non applicable NOT_YET_RECRUITING En attente / non publié Rheinburg-Klinik Switzerland · Rheinburg Klinik, Walzenenhausen, Switz… 2025-04-01 → 2028-04-30 Ouvrir
NCT03217929
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Cravi…
Active-taVNS SEP Non applicable UNKNOWN En attente / non publié Federal University of São Paulo Brazil · Federal University of São Paulo, São Paulo, … 2017-10 → 2019-10 Ouvrir
NCT02974959
Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury
gammaCore active device SEP Phase 1 COMPLETED En attente / non publié CentraCare United States · Hennepin County Medical Center, Minne… 2016-10 → 2020-11 Ouvrir
NCT06871306
Effects of Left and Bilateral Transcutaneous Auricular Vagus Nerve Stim…
transcutaneous auricular vagus ne… SEP Non applicable COMPLETED En attente / non publié Rheinburg-Klinik Turkey (Türkiye) · Sancak Tıp Merkezi, Istanbul, Turk… 2021-08-02 → 2022-10-31 Ouvrir
NCT05588063
kidNEY-VNS — taVNS for FRNS in Children
transcutaneous auricular vagus ne… SEP Non applicable RECRUITING En attente / non publié Rheinburg-Klinik United States · Children's Hospital of Philadelphia, … 2023-01-05 → 2027-08-01 Ouvrir
NCT06812585
The Effect of Metformin As an Adjuvant Therapy on Immunological Paramet…
Metformin (Cidophage®) SEP Phase 2 COMPLETED En attente / non publié German University in Cairo Egypt · Nasser Institute for Research and Treatment, … 2022-04-01 → 2025-01-30 Ouvrir
NCT02688985
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biol…
Ocrelizumab SEP Phase 3 COMPLETED En attente / non publié Hoffmann-La Roche United States, Canada, Germany, Sweden · Empire Neuro… 2016-04-29 → 2023-04-11 Ouvrir
NCT05156281
REMODEL-2 — Efficacy and Safety of Remibrutinib Compared to Teriflunomi…
Remibrutinib SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Novartis Pharmaceuticals United States, Argentina, Brazil, Bulgaria, Canada, C… 2021-12-13 → 2030-10-30 Ouvrir
NCT07932262
An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CAR…
CAR-T cells targeting CD19 SEP Phase 1/2 NOT_YET_RECRUITING En attente / non publié University Hospital Tuebingen Germany · University Hospital , Department of Interna… 2027-01 → 2028-09 Ouvrir
NCT05925049
A Study Utilising Data From European Union (EU) National Multiple Scler…
natalizumab SEP À vérifier COMPLETED En attente / non publié Biogen United States · Research Site, Cambridge, United Stat… 2023-06-30 → 2026-10-29 Ouvrir
NCT07930624
A Study to Investigate Long-term Safety and Tolerability of Frexalimab …
Frexalimab SEP Phase 3 NOT_YET_RECRUITING En attente / non publié Sanofi Non communiqué 2027-02-15 → 2031-05-16 Ouvrir
NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple …
Orelabrutinib SEP Phase 3 RECRUITING En attente / non publié Liu Qing United States, Australia, Bulgaria, Canada, Croatia, … 2026-03-23 → 2030-07 Ouvrir
NCT06733922
ELIOS - Investigational Biomarkers to Track Disease Modification in Act…
ETNATM-ProgMS SEP Phase 4 RECRUITING En attente / non publié Novartis Pharmaceuticals Canada · Novartis Investigative Site, Burnaby, Canada… 2024-11-27 → 2029-03-31 Ouvrir
NCT06900192
A Multicenter Phase 1 Study of Orca-Q in Primary Progressive Multiple S…
Orca-Q SEP Phase 1 NOT_YET_RECRUITING En attente / non publié Orca Biosystems, Inc. Non communiqué 2027-03 → 2032-12 Ouvrir
NCT05245344
Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration …
peripheral blood withdrawal SEP À vérifier COMPLETED En attente / non publié Neuromed IRCCS Italy · Centre for Experimental Neurological Therapie… 2023-01-15 → 2023-10-31 Ouvrir
NCT07935031
A Study of IMS001 in Patients With Multiple Sclerosis
IMS001 SEP Phase 1 RECRUITING En attente / non publié Zhuhai Hengqin ImStem Biotechnolo… China · West China Hospital, Sichuan University, Chen… 2026-09-28 → 2029-12 Ouvrir
NCT06292923
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple…
Foralumab SEP Phase 2 COMPLETED En attente / non publié Tiziana Life Sciences LTD United States · Brigham and Women's Hospital, Boston,… 2023-11-15 → 2026-09-17 Ouvrir
NCT04650321
Home Based Infusions for Ocrelizumab
Ocrelizumab at home SEP Phase 4 RECRUITING En attente / non publié University of Colorado, Denver United States · Amerita, Centennial, United States 2021-03-01 → 2021-08-31 Ouvrir
NCT04640818
Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy
Cladribine Oral Tablet SEP À vérifier UNKNOWN En attente / non publié Claudio Gobbi Switzerland · Neurocenter of Southern Switzerland, Os… 2020-12-17 → 2022-10-31 Ouvrir
NCT06529406
COAST — Prospective Evaluation of Sequencing From antiCD-20 Therapies t…
Ozanimod SEP Phase 4 RECRUITING En attente / non publié University of Colorado, Denver United States · Cleveland Clinic, Cleveland, United S… 2024-07-29 → 2029-08-01 Ouvrir
NCT06141486
FREVIVA — Efficacy and Safety Study of Frexalimab (SAR441344) in Adults…
Frexalimab SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Sanofi United States, Argentina, Australia, Belgium, Brazil,… 2023-12-27 → 2028-03-24 Ouvrir
NCT04480853
SPRING — Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥…
Fingolimod SEP Phase 4 ACTIVE_NOT_RECRUITING En attente / non publié Novartis Pharmaceuticals Taiwan · Novartis Investigative Site, Kaohsiung City,… 2020-10-12 → 2026-11-15 Ouvrir
NCT04178005
Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
Cladribine SEP Phase 4 ACTIVE_NOT_RECRUITING En attente / non publié University of Texas Southwestern … United States · College Park Family Care Center Physi… 2020-02-19 → 2027-08 Ouvrir
NCT07914257
Non-invasive Brain Stimulation to Improve Memory in Multiple Sclerosis
High Definition transcranial Dire… SEP Non applicable NOT_YET_RECRUITING En attente / non publié The University of Texas at Dallas United States · Callier Clinical Researcher Center, R… 2026-11-01 → 2029-09-01 Ouvrir